Stockscreener 앱 받기
0.00
100.00%
-4.02
전일 마감가:
$4.02
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$4.37M
수익:
$3.29M
순이익/손실:
$-3.09M
주가수익비율:
0.00
EPS:
-1.23
순현금흐름:
$-2.46M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$161.00
Nanovibronix Inc Stock (NAOV) Company Profile
명칭
Nanovibronix Inc
전화
(914) 233-3004
주소
969 PRUITT AVE,, TYLER
NAOV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.00 | 4.37M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nanovibronix Inc 주식(NAOV)의 최신 뉴스
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research - The Manila Times
New program targets pain from nasogastric tubes left in for days - Stock Titan
Why NanoVibronix Inc. stock is seen as undervaluedJuly 2025 Momentum & AI Based Buy and Sell Signals - ulpravda.ru
Why NanoVibronix Inc. stock could outperform in 2025July 2025 Recap & Trade Opportunity Analysis Reports - ulpravda.ru
Can NanoVibronix Inc. stock sustain revenue growth2025 Risk Factors & Breakout Confirmation Trade Signals - ulpravda.ru
Is NanoVibronix Inc. (56R) stock a top pick for value investors2025 Performance Recap & Free Community Consensus Stock Picks - ulpravda.ru
Can NanoVibronix Inc. (56R) stock deliver strong annual returns2025 Short Interest & Community Verified Watchlist Alerts - ulpravda.ru
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 - GlobeNewswire
How analysts revise price targets for NanoVibronix Inc. (56R) stockJuly 2025 Levels & Fast Entry and Exit Trade Plans - ulpravda.ru
Will NanoVibronix Inc. (56R) stock beat international competitionHigh Beta Stocks & Invest Now – Opportunity Window Closing - ulpravda.ru
Envue Medical amends long term incentive plan to align with Israeli tax laws - Investing.com
ENvue Medical, Inc.Common Stock (NQ: NAOV - FinancialContent
Short Covering: Will NanoVibronix Inc stock continue dividend increases2025 Winners & Losers & High Conviction Buy Zone Alerts - moha.gov.vn
Market Outlook: Is CANF stock a top momentum playTrade Exit Summary & Daily Chart Pattern Signals - moha.gov.vn
Can NanoVibronix Inc. stock hit analyst price targets2025 Institutional Moves & Technical Pattern Recognition Alerts - Улправда
Will NanoVibronix Inc. stock continue dividend increases2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - Bölüm Sonu Canavarı
Decliners Report: Is NanoVibronix Inc. stock a dividend growth opportunity2025 Stock Rankings & Entry Point Confirmation Alerts - moha.gov.vn
Why NanoVibronix Inc. stock appeals to analystsTreasury Yields & Technical Entry and Exit Alerts - Улправда
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK - The Manila Times
[Form 3] NanoVibronix, Inc. Initial Statement of Beneficial Ownership - Stock Titan
ENvue Medical, Inc. (NAOV) director reports no beneficial ownership on Form 3 - Stock Titan
ENvue Medical (Nasdaq: FEED) details 7.96M-share resale, Series H terms - Stock Titan
Bond Watch: Will NanoVibronix Inc. (56R) stock beat international competitionSwing Trade & Free AI Powered Buy and Sell Recommendations - Улправда
UK adds ENvue Medical’s UroShield kit to NHS drug tariff - Investing.com
UK adds ENvue Medical’s UroShield kit to NHS drug tariff By Investing.com - Investing.com Australia
UK patients with long-term catheters gain NHS-backed access to new device - Stock Titan
ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK - marketscreener.com
NHS to cover new device designed to cut catheter infections in the UK - Stock Titan
NanoVibronix to change name, symbol - MSN
Envue Medical appoints veteran David Johnson as chairman - marketscreener.com
NanoVibronix Earnings Notes - Trefis
ENvue Medical Inc (FEED) Stock Earnings Transcripts - GuruFocus
ENvue Medical, Inc.: Shareholders Board Members Managers and Company Profile | US63008J8844 - marketscreener.com
News On NanoVibronix Inc. (NAOV) Now Under FEED - 富途牛牛
NanoVibronix rebrands to ENvue Medical, updates ticker - MSN
ENvue Medical, Inc. has Changed its Ticker to FEED from NAOV - marketscreener.com
NanoVibronix, Inc. has Changed its Name to ENvue Medical, Inc - marketscreener.com
NanoVibronix Rebrands to ENvue Medical, Updates Ticker - TipRanks
NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol - Investing.com
NanoVibronix to Rebrand as ENvue Medical, Ticker to Change to FE - GuruFocus
NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol By Investing.com - Investing.com Australia
NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED’ - marketscreener.com
NanoVibronix to Become ENvue Medical (NASDAQ: FEED) as New Ticker Starts Trading - Stock Titan
Rate Hike: Why NanoVibronix Inc stock is seen as undervaluedJuly 2025 Closing Moves & Short-Term High Return Ideas - moha.gov.vn
Is NanoVibronix Inc a good long term investmentChart Pattern Recognition & Access Free Risk Analysis Before You Invest - earlytimes.in
Nanovibronix, Inc. Announces Board Appointments - marketscreener.com
NanoVibronix elects new board members at annual meeting - MSN
NanoVibronix elects new board members and amends incentive plan at annual meeting - Investing.com Nigeria
NanoVibronix Elects New Board Members at Annual Meeting - TipRanks
NanoVibronix elects new board members and amends incentive plan at annual meeting By Investing.com - Investing.com South Africa
Is NanoVibronix Inc. (56R) stock a fit for income portfoliosJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
Nanovibronix Inc (NAOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.31%
0.51%
자본화:
|
볼륨(24시간):